Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms

K Poole1

  • 1Department of Microbiology and Immunology, Queen's University, Kingston, ON, Canada. poolek@post.queensu.ca

Insights

Pseudomonas aeruginosa utilizes multidrug efflux systems (MexAB-OprM, MexXY-OprM, MexCD-OprJ, MexEF-OprN) for innate and acquired resistance to antimicrobials. These pumps export various compounds, making them key targets for therapeutic intervention.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Biochemistry

Background:

  • Pseudomonas aeruginosa is an opportunistic pathogen with significant antimicrobial resistance.
  • Multidrug efflux systems, such as MexAB-OprM and MexXY-OprM, contribute to this resistance.
  • Additional systems (MexCD-OprJ, MexEF-OprN) also confer acquired resistance through gene hyperexpression.

Purpose of the Study:

  • To investigate the role of multidrug efflux systems in Pseudomonas aeruginosa.
  • To highlight the contribution of these systems to both intrinsic and acquired drug resistance.
  • To identify these efflux systems as potential therapeutic targets.

Main Methods:

  • Analysis of Pseudomonas aeruginosa's intrinsic and acquired multidrug resistance mechanisms.
  • Identification and characterization of tripartite efflux systems (RND, OMF, MFP proteins).
  • Comparative analysis of homologous systems in related bacterial species.

Main Results:

  • Identified four major tripartite efflux systems (MexAB-OprM, MexXY-OprM, MexCD-OprJ, MexEF-OprN) in P. aeruginosa.
  • Demonstrated their role in exporting antibiotics, dyes, detergents, and other compounds.
  • Observed conservation of similar systems in other bacterial species like S. maltophilia and Burkholderia spp.

Conclusions:

  • Multidrug efflux systems are critical for P. aeruginosa's resistance.
  • These systems contribute to the export of a wide range of toxic substances.
  • Targeting these conserved efflux pumps presents a promising strategy for combating P. aeruginosa infections.

Related Concept Videos

Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...